Advancements in the Treatment of High-Risk Smoldering Myeloma: News from ASH 2024
Smoldering multiple myeloma (SMM) is a precursor to symptomatic multiple myeloma (MM), characterized by its asymptomatic yet progressive nature and significant risk of progression. The management of SMM has evolved considerably in recent years with the introduction of targeted therapies. While the t...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2024-12-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2024.22.173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|